$SLQT

SelectQuote, Inc. (SLQT) filed an SEC Form 8-K — Results of Operations and Financial Condition.

Analysts at Noble Financial and UBS reiterated bullish views on SelectQuote (SLQT) and Nasdaq (NDAQ). Noble’s Michael Kupinski kept a Buy on SLQT with a $5.00 target versus a $0.69 close. UBS’s Alex Kramm kept a Buy on NDAQ with a $120 target versus a $90.42 close. TipRanks consensus targets were also cited.

SelectQuote (SLQT) stock has surged 54% in the last month after Barchart's Trend Seeker issued a "Buy" signal on April 17, despite a 72% loss over the past year. Analysts project significant earnings growth for next year, though current Wall Street sentiment is mixed. The article suggests SLQT as a speculative rebound candidate for investors looking for beaten-down stocks starting to recover.

SelectQuote Inc. (NYSE: SLQT) received a notice from the NYSE due to its common stock trading below $1.00 per share for 30 consecutive trading days. The company has a six-month cure period to regain compliance, needing its stock to close at or above $1.00 with an average closing price of at least $1.00 over the preceding 30 days. Despite the current low stock price and the delisting notice, InvestingPro analysis suggests the stock may be undervalued, and the company recently reported stronger-than-expected Q2 fiscal year 2026 earnings and launched a new franchise model.

SelectQuote (SLQT) has received a notice from the NYSE regarding non-compliance, as its average share price dropped below $1 for 30 consecutive trading days. The company has a six-month window to regain compliance, with management planning to leverage strong recent financial results, including a new $415 million credit facility, to support its position. Spark, TipRanks' AI Analyst, rates SLQT as Neutral, citing improving fundamentals and a constructive earnings outlook, but is tempered by weak technicals and inconsistent cash flow.

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of SelectQuote, Inc. (NYSE: SLQT) investors. The investigation focuses on whether SelectQuote and its officers engaged in corporate wrongdoing, specifically for those who purchased securities before September 9, 2020, and continue to hold them. The firm encourages affected stockholders to contact them to learn more and potentially assist in the investigation, offering their services on a contingency fee basis.

SelectQuote (SLQT) is projected to announce its Q2 2026 earnings before market open on Thursday, February 5th. Analysts anticipate earnings of $0.17 per share and revenue of $530.7260 million for the quarter. The company's stock currently trades at $1.49, with institutional investors holding 34.59% of shares, and analysts currently have a consensus "Hold" rating with a target price of $3.88.

Pathlight Capital has acted as the administrative agent for a $415,000,000 senior secured credit facility for SelectQuote, Inc. This press release announces the financial arrangement. The article also briefly mentions Unity Software's fourth-quarter financial results, including a 35% year-over-year revenue increase to $609 million and a loss of 66 cents per share.

SelectQuote, Inc. (NYSE:SLQT) recently experienced a 10% share price decline, adding to a 56% loss over the past year. Institutional investors, who hold 44% of the company's shares, are particularly affected by these losses and may need to consider drastic measures. No single shareholder holds a majority, with the top 25 investors collectively owning 50% of the company, while insiders own shares valued at US$21 million and the general public holds a 38% stake.

BOSTON, Nov. 24, 2025 ( GLOBE NEWSWIRE ) -- Berman Tabacco, a national law firm representing investors, announces its investigation into potential stockholder claims involving SelectQuote, Inc. ( "SelectQuote" ) ( NYSE:SLQT ) allegedly receiving illegal payments from health insurance providers.